4
Changes in Ownership
Intellia Therapeutics, Inc. Filed Acc 0001209191-23-044257
Director sold 265 shares at $42.33 ($11,217)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bhanji Muna Director | 2023-07-31 | Sale 10b5-1 | −265 | $42.33 | $11,217 | 12,261 | D |
| Open-market sales · 265 sh · avg $42.33 · $11,217 | |||||||
Loading xslF345X05/doc4.xml…